JPMorgan Chase & Co. cut shares of Harmony Gold Mining Co. (ADR) (NYSE:HMY) from an overweight rating to a neutral rating in a research report sent to investors on Thursday morning, TheFlyOnTheWall.com reports. Harmony Gold Mining Co. (ADR) (NYSE:HMY) stock opened at $2.94 in last trading session, and closed at $3.09, trading in the range of $2.92 – $3.10. The stock showed a positive weekly performance of 9.57%.
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) average recommendation is underweight with average Target Price of $1.00. ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) shares closed at $4.56 on last trade day, by gaining 12.04%. Stock 52 week range is $1.49 – $5.95. Company’s market capitalization is $456.00 million.
Research analysts at Barclays hoisted their price target on shares of AK Steel Holding Corp. (NYSE:AKS) from $8.00 to $10.00 in a report released on Wednesday, American Banking News.com reports. The firm currently has an “overweight” rating on the stock. Barclays’ price target points to a potential upside of 40.65% from the stock’s previous close. AK Steel Holding Corporation (NYSE:AKS) stock advanced 5.09% and finished the last session at $6.61. The EPS of the stock remained -0.35. Company’s market capitalization is $901.47 billion.
Shares of InvenSense (NASDAQ:INVN) reached a new 52-week high on Tuesday after Robert W. Baird raised their price target on the stock from $20.00 to $23.00, American Banking News.com reports. The stock traded as high as $22.09 and last traded at $21.57, with a volume of 5,898,398 shares changing hands. The stock had previously closed at $19.58. InvenSense Inc (NYSE:INVN) stock opened at $21.01 in last trading session and closed at $21.69. The 52 week range of the stock is $9.09 – $22.09 and the day range was $20.61 – $22.09.